Document Detail


Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.
MedLine Citation:
PMID:  24253538     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cystinuria is a genetic cause of recurrent kidney stones which may be more recurrent and larger than more common non-cystine stones. They may have a greater impact on health-related quality of life (HRQoL). We measured this impact by surveying HRQoL in patients with stones, comparing non-cystine stone formers (NCSF) to cystine stone formers (CYSF) and both groups to normative values of the US population. We used SF-36v2 via an internet instrument. CYSF patients were recruited via cystinuria-related websites, two patient advocacy groups, and an active endourology practice. NCSF patients were recruited from the same practice and by email. Total n surveyed with scorable data: 214 CYSF and 81 NCSF. The participants included 128 men and 161 women. The group of CYSF were significantly younger (39 vs. 54 years) and suffered longer from kidney stones (255 vs. 136 months). CYSF patients had significantly more episodes of stones than NCSF patients in the last year (N = 108 CYSF, N = 20 NCSF). More frequent stones in the last year and mental comorbidities most often predicted worse scores in the individual HRQoL domains. However, cystine stone composition was a significant predictor of worse scores only for role emotional. Better scores in all SF-36 domains were associated with greater time since the last kidney stone event. Although kidney stones are often transient, kidney stone formers, regardless of stone composition, have a worse HRQoL than the standard US population, which has a normative score of 50, such as general health (41.2 ± 12.8), bodily pain (46.5 ± 11.8) and mental health (45.1 ± 12.6). CYSF are more frequent and severe stone formers compared with NCSF with a resulting greater, direct impact on the HRQoL of CYSF patients. Whether preventive strategies for cystinuria are being properly utilized by practitioners, and which strategies are most effective, should be established.
Authors:
Frank Modersitzki; Laura Pizzi; Michael Grasso; David S Goldfarb
Related Documents :
24936718 - High-power thulium laser vaporization of the prostate: short-term outcomes of safety an...
2666218 - Type 1 (insulin-dependent) diabetes in japanese children is not a uniform disease.
3827358 - Subtotal resection of the head of the pancreas combined with ductal obliteration of the...
23884638 - Fatigue management in patients with ibd: a randomised controlled trial.
8128328 - The role of endoscopic thrombin injections in the treatment of gastroduodenal bleeding.
10444118 - Desmopressin in the treatment of nocturnal polyuria in the male.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-11-20
Journal Detail:
Title:  Urolithiasis     Volume:  -     ISSN:  2194-7236     ISO Abbreviation:  Urolithiasis     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-11-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101602699     Medline TA:  Urolithiasis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Kidney Stone Prevention Programs, Nephrology Section/111G, DVAMC, New York Harbor VA Medical Center and NYU School of Medicine, 423 E. 23 St., New York, NY, 10010, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel titanium-based O3-type NaTi0.5Ni0.5O2 as a cathode material for sodium ion batteries.
Next Document:  Retrograde intrarenal surgery in patients with isolated anomaly of kidney rotation.